Slit2 Antibody (710305) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB5444JF635
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Recombinant Monoclonal Rat IgG2B Clone # 710305
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant mouse Slit2
Gln26-Gln900
Accession # Q9R1B9
Gln26-Gln900
Accession # Q9R1B9
Specificity
Stains human and mouse Slit2 transfectants but not irrelevant transfectants in flow cytometry.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2B
Applications for Slit2 Antibody (710305) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Slit2
Long Name
SLIT Homolog 2
Alternate Names
SLIL3
Gene Symbol
SLIT2
Additional Slit2 Products
Product Documents for Slit2 Antibody (710305) [Janelia Fluor® 635]
Product Specific Notices for Slit2 Antibody (710305) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...